FTC sues major pharmacy profit administrators about insulin price ranges The company introduced action towards Caremark, Express Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating methods “artificially inflated” the list cost of daily life-preserving insulin medication. Sanders quickly condemned the shift in an announcement Wednesday, noting he was https://label-the-figure-with-the16050.digitollblog.com/30431922/not-known-factual-statements-about-healthcare-news